New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
09:55 EDTSTEM, CUR, OSIR, ASTM, BTX, GERNSupreme Court turns down appeal over stem cell research, SCOTUSblog says
The Supreme Court turned down an appeal by scientists seeking to stop all studies on embryonic stem cells, according to SCOTUSblog. The Fly notes that companies engaged in the research, development, and commercialization of stem cell therapies include StemCells (STEM), Neuralstem (CUR), Aastrom Biosciences (ASTM) and Osiris Therapeutics (OSIR). Also, earlier this morning, BioTime (BTX) entered into an agreement to acquire the intellectual property, including patents and patent applications, and other assets related to Geron's (GERN) human embryonic stem cell programs. Reference Link
News For STEM;CUR;OSIR;ASTM;BTX;GERN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 17, 2014
08:05 EDTOSIROsiris, Arthrex announce exclusive commercial and development partnership
Subscribe for More Information
October 16, 2014
15:22 EDTGERNGeron volatility increases to 134
Geron overall option implied volatility of 134 is above its 26-week average of 106 according to Track Data, suggesting large price movement.
October 9, 2014
17:31 EDTASTMAastrom to change name to Vericel Corporation, move headquarters
Subscribe for More Information
09:19 EDTCURNeuralstem treats first patient in Phase I spinal cord injury stem cell trial
Subscribe for More Information
October 7, 2014
08:14 EDTSTEMStemCells initiates Phase II clinical trial using HuCNS-SC
Subscribe for More Information
07:24 EDTOSIR, STEM, ASTMAlliance for Regenerative Medicine
Subscribe for More Information
October 6, 2014
08:02 EDTBTXBioTime unit files IND with FDA for OpRegen
Subscribe for More Information
07:07 EDTBTXBioTime to raise $31M through sale of shares
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use